{'fraction_non_alphanumeric': 0.02702702702702703, 'fraction_numerical': 0.0, 'mean_word_length': 5.387931034482759, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Management of molar pregnancy.

Gestational Trophoblastic Disease (GTD) originates from placental tissue and is among the rare human tumors that can be cured even in the presence of wide- spread metastases. GTD include a spectrum of interre-lated tumors including complete and partial hydatidi- form mole, invasive mole, choriocarcinoma, and placental site trophoblastic tumor, that have different pro- pensities for local invasion and spread. Although most GTD develop after a mole, they can follow any antece- dent pregnancy. Transvaginal ultrasound, routinary dosage of beta-hCG and current approaches to chemotherapy, let most women with malignant gestational trophoblastic disease to be cured and their reproductive function preserved.